Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
Clinical trial NCT05320393 · COMPLETED
Trial details
- NCT number
- NCT05320393
- Sponsor
- Evolus, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2023-05-22
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.